Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factor.
about
Potential therapeutic impact of CD13 expression in non-small cell lung cancerpHLIP-mediated targeting of truncated tissue factor to tumor vessels causes vascular occlusion and impairs tumor growthNG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.Chimeric antigen receptor-modified T Cells inhibit the growth and metastases of established tissue factor-positive tumors in NOG miceLow-Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue Factor.Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imaging.Modification of daunorubicin-GnRH-III bioconjugates with oligoethylene glycol derivatives to improve solubility and bioavailability for targeted cancer chemotherapy.Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
P2860
Q30313110-13E1E8F5-1F35-44B7-A849-E694019EEC34Q36414221-DF165A4D-BA5A-46D7-8455-930DC1C4B1BEQ36916334-825220C7-A15B-4DF4-9A90-E8DA04409139Q37696156-DF862A85-9427-44D9-9140-FFF6620C372AQ37705993-D48FA0BE-7ED0-499F-8395-40B2A516A400Q38859984-C3E20EB9-ED75-4605-95B4-6AB5C7DF3383Q39077187-2C9BBF93-447F-41E5-B17B-7E38608FCE72Q53589895-3B7AC2FA-2DA4-4880-BB09-A7EEC3546C29Q58768458-DF0135A5-F22C-4B52-B65E-255D63FE3FF1
P2860
Anticancer therapy by tumor vessel infarction with polyethylene glycol conjugated retargeted tissue factor.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anticancer therapy by tumor ve ...... ated retargeted tissue factor.
@en
Anticancer therapy by tumor ve ...... ated retargeted tissue factor.
@nl
type
label
Anticancer therapy by tumor ve ...... ated retargeted tissue factor.
@en
Anticancer therapy by tumor ve ...... ated retargeted tissue factor.
@nl
prefLabel
Anticancer therapy by tumor ve ...... ated retargeted tissue factor.
@en
Anticancer therapy by tumor ve ...... ated retargeted tissue factor.
@nl
P2093
P356
P1476
Anticancer therapy by tumor ve ...... ated retargeted tissue factor.
@en
P2093
Alena Dreiling
Caroline Zerbst
Carsten Höltke
Christian Schwöppe
Christoph Schliemann
Jörg Stypmann
Laura Overkamp
Martin Lücke
Max Fröhlich
Richard Holtmeier
P304
P356
10.1021/JM301669Z
P407
P577
2013-03-15T00:00:00Z